Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.
about
Prevention and Treatment of Recurrent Hepatitis B after Liver TransplantationChange of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationApplication of nucleoside analogues to liver transplant recipients with hepatitis BManagement of patients with hepatitis B in special populationsManagement of viral hepatitis in liver transplant recipientsAntiviral therapies for hepatitis B virus-related hepatocellular carcinoma.Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.Accurate Detection of Hepatitis B Virus G1896A Mutant by Developed Taqman-ARMS Followed a Strict Control System.Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative.One-year extended, monthly vaccination prophylaxis combined with hepatitis B immune globulin for hepatitis B after liver transplantation.New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.
P2860
Q26751777-93F3894E-F43F-43DE-A358-23586EAF952DQ26784241-57D1CE7F-45A2-4FC4-BB22-7D10A0C2EB00Q26859796-DFD578FA-C006-4E80-8166-23D86593FC74Q27016136-8B616E23-1AC7-4FB4-A437-317B8B8FC4C4Q34779730-50659D99-3754-4268-9488-15FC4A1334A6Q35270193-5AB99F9F-2F02-4D49-BC4E-110062BC4D76Q35715908-C49804F5-65F9-4305-A8E1-9BD2CC863CCEQ38447283-E74F3BB8-5DA7-4C23-AF84-3BB021D647ABQ38646776-F4BEF25C-2ED1-42F0-968A-7C59214F7E8FQ41062056-EB921D84-57D0-4488-BF1F-A9390166E387Q41668771-7CA79A40-FBDE-4816-82C1-4379345E61A7Q41742518-A8EC233E-635C-4BB9-87DF-20C64E2D0226Q41755402-DDD3730C-1394-4B79-A967-425AB859E3B6Q42146642-D1E49E94-6B75-4FCD-9C10-B7A3F9446164Q42213645-F60350D3-924F-4DC7-81D7-22C6266A8755Q52620441-345F8915-51C5-4D3A-B375-6E754F081C36
P2860
Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review of the pharmacological ...... d after liver transplantation.
@en
type
label
Review of the pharmacological ...... d after liver transplantation.
@en
prefLabel
Review of the pharmacological ...... d after liver transplantation.
@en
P2860
P356
P1476
Review of the pharmacological ...... d after liver transplantation.
@en
P2093
Evangelos Cholongitas
P2860
P304
P356
10.3748/WJG.V19.I48.9189
P407
P577
2013-12-01T00:00:00Z